Sandra and Edward Meyer Cancer Center

A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study led by researchers at Weill Cornell Medicine, the New York Genome Center and the Princess Margaret Cancer Centre in Toronto.

The $9.8 million, five-year grant awarded to Weill Cornell Medicine and Columbia University will help combat cancer disparities fueled by persistent poverty.

Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions.

Weill Cornell Medicine has received a grant from the National Institutes of Health (NIH) as part of a new $140 million Common Fund program to study somatic mosaicism, a phenomenon in which organs and tissues develop significant genetic differences across their cell populations.

Dr. Tobias Meyer, the Joseph C. Hinsey Professor in Cell and Developmental Biology at Weill Cornell Medicine, has been elected to the American Academy of Arts and Sciences.

Dr. James C. Lo, an associate professor of medicine and Dr. Lisa G. Roth, an associate professor of pediatrics, both from Weill Cornell Medicine, were elected members of the American Society for Clinical Investigation (ASCI) for 2023.

A Cornell University alumnus, Meyer ’49, along with his beloved wife Sandra, was a generous and committed champion of Weill Cornell Medicine, with an enduring passion for medical research and philanthropy.

White blood cells called neutrophils have an unappreciated role in eradicating solid tumors.

Dr. Ekta Khurana, an associate professor of physiology and biophysics at Weill Cornell Medicine, has received a 3-year, $1.2 million grant from the United States Department of Defense to investigate how prostate cancer cells evolve to become resistant to hormone-blocking therapy. 

A small but significant metabolic difference between human and mouse lung tumor cells, has been discovered by Weill Cornell Medicine researchers, explaining a discrepancy in previous study results, and pointing toward new strategies for developing cancer treatments.

Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute, part of the National Institutes of Health, to investigate the molecular mechanisms by which immune cells called B cells interact with Epstein-Barr virus (EBV) to cause lymphoma, particularly in people living with HIV.

Two new grants from The Leukemia & Lymphoma Society (LLS) will support Weill Cornell Medicine’s pathbreaking research on the origins of lymphomas and on treatments that exploit these cancers’ biological vulnerabilities.

Surgery that removes only a portion of one of the five lobes that comprise a lung is as effective as the traditional surgery that removes an entire lobe for certain patients with early-stage lung cancer.

Two Weill Cornell Medicine faculty members, Dr. David Lyden and Dr. Harel Weinstein have been elected fellows of the American Association for the Advancement of Science (AAAS).

A protein that prepares DNA for replication also prevents the replication process from running out of control, according to a new study by Weill Cornell Medicine researchers.

The key to understanding how the most aggressive lymphomas arise and resist current therapies may lie in mutations that disrupt a critical natural selection process among antibody-producing B cells.

A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack.

A new method can illuminate the identities and activities of cells throughout an organ or a tumor at unprecedented resolution.

An enzyme that defends human cells against viruses can help drive cancer evolution towards greater malignancy by causing myriad mutations in cancer cells.

An experimental therapy showed promise as treatment for an aggressively spreading type of colorectal cancer in preclinical models.